The largest database of trusted experimental protocols

C9481

Manufactured by Merck Group

C9481 is a laboratory equipment product from Merck Group. It is a specialized device designed for use in scientific research and analysis. The core function of this product is to perform specific tasks within a laboratory environment, however, a detailed description without extrapolation or interpretation is not available.

Automatically generated - may contain errors

2 protocols using c9481

1

Enzalutamide and PTC Inhibitors in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were commercially obtained and used at the designated concentrations (unless otherwise indicated): enzalutamide (IN034, Dieckmann), PTC209 (0, 0.5, 1, 2, and 4 μM, HY-15888, MedChem Express), PTC596 (0, 0.005, 0.01, 0.02, 0.04 and 0.08 μM, PTC Therapeutics), and DHT (A8380, Sigma). enzalutamide were diluted in a vehicle of 0.5% CMC (C9481, Sigma) and 0.25% Tween-80 (P8074, Sigma). PTC209 and PTC596 were diluted in a vehicle of 14% DMSO, 36% polyethylene glycol 400, and 50% polypropylene glycol 400. DHT was dissolved in ethanol and diluted using charcoal-stripped serum medium to 10 nM. Protein lysates were prepared in SDS-sample buffer (4× reducing, BP-110R, Boston BioProducts). The secondary antibodies were Clean-Blot IP Detection Reagent (HRP, 21230, Thermo Scientific), goat antimouse IgG (H+L)-HRP (SA001–500, GenDEPOT), or goat anti-rabbit IgG (H+L)-HRP (SA002-500, GenDEPOT). Antibodies used for immunoblot assays are listed in Supplementary Table 4.
+ Open protocol
+ Expand
2

SARS-CoV-2 Virus Titration and Plaque Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 was titrated with virus plaque assay on Vero E6 cells. Virus stocks were serially diluted in virus titration media (VTM, DMEM supplemented with 5% fetal calf serum, 2 mM l-glutamine, 100 IU/mL penicillin, and 100 μg/mL streptomycin) and titrated on 24-well plates. The virus inoculum was added on the Vero E6 cells and incubated at 37°C. After 1 h, the inoculum was removed and the cell were overlaid with VTM supplemented with 1.5% carboxymethylcellulose (medium viscosity, C9481, Sigma-Aldrich) and incubated at 37°C. The overlay was removed from the cell at 3 hpi and the plates were fixed by submerging them in a tank of 6% formaldehyde (methanol stabilized) for at least 1 h. The cell monolayer was stained with crystal violet and the plaques were quantified by visual inspection with microscope. Virus supernatants were titrated in a similar fashion on 96-well plates.
For plaque purification, Vero E6 cells seeded in 24-well plate were infected with 10 PFU of early passage FI-P4 strain. After 1 h of infection, the inoculum was removed, and cells were overlaid with VTM supplemented with 1.5% carboxymethylcellulose and incubated at 37°C for 3 days. Plaques were identified under the inverted microscope and well-separated plaques were picked by scratching with 200-μL pipette tips. The tips were transferred to Vero E6 cells in a T25 flask to recover the virus.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!